Image de couverture de livre

RMST for Interval‐Censored Data in Oncology Clinical Trials

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Xiyuan Gao, Tianmeng Lyu, Menghao Xu, Lisa V. Hampson, Yan Du, Renxin Lin, Nigel Yateman, Lu Tian, Jianguo Sun
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Statistics in Medicine
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

An Augmented Approach for Regression Analysis of Case‐Cohort Interval‐Censored Failure Time Data
par: Yichen Lou, et autres
Publié: (2025)

On Window Mean Survival Time With Interval‐Censored Data
par: Takuto Iijima, et autres
Publié: (2026)

Mediation Analysis of Failure Time Data Under Interval Censoring
par: Yanpeng Shi, et autres
Publié: (2026)

Interpretable Deep Regression Models With Interval‐Censored Failure Time Data
par: Changhui Yuan, et autres
Publié: (2026)

Sieve Maximum Likelihood Estimation of Partially Linear Transformation Models With Interval‐Censored Data
par: Changhui Yuan, et autres
Publié: (2024)

Identification of Regions of Interest in Neuroimaging Data With Irregular Boundary Based on Semiparametric Transformation Models and Interval‐Censored Outcomes
par: Chun Yin Lee, et autres
Publié: (2025)

Predicting Individual Risk of Advanced Adenoma Based on the Interval‐Censored Recurrent Adenoma Event and Informative Screening Time
par: Yipeng Wei, et autres
Publié: (2026)

Model‐Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival
par: Xuan Wang, et autres
Publié: (2025)

Assurance methods for designing a clinical trial with a delayed treatment effect
par: James A. Salsbury, et autres
Publié: (2024)

Random Survival Forest for Censored Functional Data
par: Giuseppe Loffredo, et autres
Publié: (2025)

Robust Estimation of Additive Shared‐Frailty Models for Recurrent Event Data With Dependent Censoring
par: Xin Chen, et autres
Publié: (2025)

Generalized Estimating Equations for Survival Data With Dependent Censoring
par: Lili Yu, et autres
Publié: (2024)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
par: Maria Vittoria Chiaruttini, et autres
Publié: (2026)

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
par: Ruoyuan Qian, et autres
Publié: (2025)

Gaussian Process Regression for Value‐Censored Functional and Longitudinal Data
par: Adam Gorm Hoffmann, et autres
Publié: (2025)

Weighted Expectile Regression Neural Networks for Right Censored Data
par: Feipeng Zhang, et autres
Publié: (2024)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
par: Jingya Gao, et autres
Publié: (2024)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
par: David S. Robertson, et autres
Publié: (2025)

Bayesian Estimation of Partial Functional Tobit Censored Quantile Regression Model
par: Chunjie Wang, et autres
Publié: (2025)

Proportional Mean Residual Life Model With Varying Coefficients for Right Censored Data
par: Bing Wang, et autres
Publié: (2025)

Bland–Altman Plot for Censored Variables
par: Anne Lotz, et autres
Publié: (2025)

Futility Monitoring in Clinical Trials
par: Ana M. Ortega‐Villa, et autres
Publié: (2025)

Joint Frailty Mixture Cure Model for Recurrent Event Data With Dependent Censoring: An MCEM Approach
par: Nasrin Sultana, et autres
Publié: (2026)

Finite Mixtures of Multivariate t Linear Mixed‐Effects Models for Censored Longitudinal Data With Concomitant Covariates
par: Tsung‐I Lin, et autres
Publié: (2026)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I– II Oncology Dose Finding Trials
par: Andrew Hall, et autres
Publié: (2026)

A Bayesian Parametric and Nonparametric Approach for the Imputation of Multivariate Left‐Censored Data Due to Limit of Detection
par: Federico L. Perlino, et autres
Publié: (2025)

Efficient estimation of Cox model with random change point
par: Xuerong Chen, et autres
Publié: (2024)

Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data
par: Guoqiao Wang, et autres
Publié: (2024)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
par: Guoqiao Wang, et autres
Publié: (2025)

An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
par: Erik W. van Zwet, et autres
Publié: (2026)

Testing for Similarity of Dose Response in Multiregional Clinical Trials
par: Holger Dette, et autres
Publié: (2025)

Patient‐Centric Pragmatic Clinical Trials: Opening the DOOR
par: Scott R. Evans, et autres
Publié: (2026)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
par: Alessandra Serra, et autres
Publié: (2025)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
par: Gi‐Ming Wang, et autres
Publié: (2026)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
par: Yuwei Cheng, et autres
Publié: (2026)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
par: Fei Gao, et autres
Publié: (2025)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
par: Yuan Li, et autres
Publié: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
par: Adrien Ollier, et autres
Publié: (2025)

Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
par: Kim May Lee, et autres
Publié: (2026)

Generalized Method of Moments in Analyzing Recurrent Events for Semiparametric Transformation Models With Informative Censoring
par: Yu‐Jen Cheng, et autres
Publié: (2025)